From De-Extinction to Deep-Tech Titan: Colossal Biosciences Eyes Massive $30 Billion Valuation
In the realm of speculative science, the line between science fiction and commercial reality is thinning. Colossal Biosciences, the five-year-old startup that captured global headlines with its ambitious—and controversial—plan to…
